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Abstract
Microglial cells are normally activated in response to brain injury or immunological stimuli
to protect central nervous system (CNS). However, over-activation of microglia conversely
amplifies the inflammatory effects and mediates cellular degeneration, leading to the death
of neurons. Recently, cordycepin, an active component found in Cordyceps militarisa
known as a rare Chinese caterpillar fungus, has been reported as an effective drug for treat-
ing inflammatory diseases and cancer via unclear mechanisms. In this study, we attempted
to identify the anti-inflammatory role of cordycepin and its protective effects on the impair-
ments of neural growth and development induced by microglial over-activation. The results
indicate that cordycepin could attenuate the lipopolysaccharide (LPS)-induced microglial
activation, evidenced by the dramatically reduced release of TNF-α and IL-1β, as well as
the down-regulation of mRNA levels of iNOS and COX-2 after cordycepin treatment. Be-
sides, cordycepin reversed the LPS-induced activation of NF-κB pathway, resulting in anti-
inflammatory effects. Furthermore, by employing the conditioned medium (CM), we found
cordycepin was able to recover the impairments of neural growth and development in the
primary hippocampal neurons cultured in LPS-CM, including cell viability, growth cone ex-
tension, neurite sprouting and outgrowth as well as spinogenesis. This study expands our
knowledge of the anti-inflammatory function of cordycepin and paves the way for the bio-
medical applications of cordycepin in the therapies of neural injuries.
Introduction
Cordycepin, 3’-deoxyadenosine, an active component found in Cordyceps militarisa known as
a rare Chinese caterpillar fungus, has been shown to be beneficial to circulatory, immune, re-
spiratory and glandular systems in human body [1]. Given the biological effects including
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anti-fungal, anti-tumorigenic on some cell lines and anti-diabetic effects, cordycepin has been
proposed to be used in the therapies against several diseases including inflammatory diseases
and cancer [2–4]. Also, accumulating evidences suggested that cordycepin is able to affect cen-
tral nervous system (CNS) and exert neuro-protective effects after cerebral ischemia or reperfu-
sion injury [5, 6]. Recently, cordycepin was found to be capable of reducing excessive nitric
oxide (NO), prostaglandin E2 (PGE2) and pro-inflammatory cytokine production, as well as in-
hibiting the eukaryotic transcription factor nuclear factor-kappa B (NF-κB) translocation by
suppressing IkappaB-α (IκB-α) degradation, protein kinase B (Akt), ERK-1/2, JNK, and p38
kinase and mitogen-activated protein kinases (MAPK) signaling pathways to reduce lipopoly-
saccharide (LPS)-stimulated inflammation in murine BV2 microglia without causing cytotox-
icity [7]. This finding provides a novel treatment for neurodegenerative diseases by repressing
the productions of inflammatory mediators in microglia. However, the mechanisms of the
anti-inflammatory effects of cordycepin on microglia still remain ambiguous.
Microglia is a type of immune cells in the CNS. These macrophage-like cells are normally
activated in response to brain injury or immunological stimuli [8, 9]. Microglia has been dem-
onstrated to participate in brain remodeling and maturation as it eliminates cells deemed to be
cleared [10, 11]. Additionally, they also serve as immune surveillance and host defense protect-
ing against invading microorganisms and neoplastic cells in the matured brain [12]. However,
whether the activation of microglia plays a role in the neuronal death remains elusive since am-
plifying the inflammatory effects and mediating cellular degeneration in contrast to protecting
CNS by activated microglia was observed. The activation of microglial cells with the dramatic
up-regulations of their surface receptors promotes the secretions of a variety of soluble factors,
including glia-derived neurotrophic factor that potentially assists the survival of neurons [13].
Simultaneously, it also facilitates the production of some proinflammatory and neurotoxic fac-
tors such as cytokines tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), free radi-
cals, fatty acid metabolite and quinolinic acid [13].In turn, the excessive activated microglial
cells induced by subtle changes in their micro-environment or pathological insults, can be dele-
terious to neurons and propagate neuronal injury [14, 15]. Uncontrolled activated microglia
was proposed to have reduced capacity to protect neurons instead promote neurotoxity by re-
leasing inflammatory mediators and cause bystander injury to neurons [12, 16]. In this case,
the regulation of neuroinflammation by microglia functions as a double-edged sword in main-
taining brain health [17]. Accumulating evidence linked neuroinflammation to the pathogene-
sis of several diseases such as Alzheimer’s and Parkinson diseases as well as several psychiatric
disorders such as schizophrenia (SCZ) and depression [18–21]. Although the mechanisms of
these diseases are still unclear, the overactivation of microglia is increasingly accepted as an im-
portant role in pathogenesis of these diseases.
In this study, we aim to investigate the neural protective effects of cordycepin against the
impairments induced by microglial over-activation. We first studied the anti-inflammatory ef-
fects of cordycepin and the underlying mechanisms. Then we explored the beneficial effects of
cordycepin on the impairments of neural growth and development in the primary hippocam-
pal cultured neurons. The results revealed that cordycepin can alleviate the inflammation by
microglial over-activation and protect the neurons against the following injuries.
Materials and Methods
Cell Culture
Microglia (BV2 cells) were purchased from the Shanghai Baili Biology Company (Shanghai,
China). For the BV2 culturing, the cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM; Gibco, USA) supplemented with 10% fetal bovine serum (FBS; Gibco), 100 U/mL
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penicillin and 100 mg/ml streptomycin (Gibco) at 37°C in a 5% CO2 humidified air environ-
ment. The different concentrations of cordycepin (1, 10, 20, 40 μg/ml) (Sigma, St. Louis, MO,
USA) were added to the culture medium for the cordycepin treatment.
For the culturing of hippocampal neurons, the hippocampus of both hemispheres hippo-
campus was dissected from the brain of prenatal mouse. Cells were gently dissociated by pi-
pette tips after digested in TryplE (Life Technologies, USA) for 15 min at 37°C. Cell suspension
was then centrifuged at 1000 rpm for 5 min, and the pellet was resuspended in culture medium
(DMEMmedium containing 10% FBS, 2% B-27 supplement, penicillin-streptomycin, Ham’s
F-12 Nutrient Mixture). Cultures were maintained at 37°C in humidified atmosphere with 5%
CO2 and medium was changed 24 h after plating and every 3 days thereafter. To inhibit glial
cell proliferation, on the second day we treated the culture with 5 μM cytosine-β-D-arabinofur-
anoside (Ara-C, Sigma). Neurons cultured for 7 to 21 days were used in the experiments. This
study was carried out in strict accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved
by the Committee on the Ethics of Animal Experiments of Wuzhong Hospital. The IACUC
committee members at Wuzhong Hospital approved this study. All surgery was performed
under 0.3% sodium pentobarbital (1 mL/100g) anesthesia. The animals were sacrificed by CO2
inhalation followed by decapitation and all efforts were made to minimize suffering.
Cell viability
Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) assay. Briefly, the cells were cultured in 96 well plates and the medium was removed
and the cells were incubated with 0.5 mg/ml MTT solution for 4 h at 37°C. The supernatant
was then discarded and the formed formazan crystals in each well were dissolved in DMSO
(0.1%). The absorbance was measured at 490 nm with a Microplate reader (VictorTM ×4, Per-
kinElmer, Singapore). Cell viabilities were normalized to the control.
LDH assay
The integrity of cells was evaluated by Lactase Dehydrogenase (LDH) assay following the pro-
tocol of CytoTox-ONE Homogeneous Membrane Integrity Assay kit (Promega, USA). The as-
says were performed after 7 days of culture. The data were recorded by a Multilabel Reader
(Victor ×4, PerkinElmer, Singapore) and transparency characteristics of the substrates permit-
ted an online observation of the cells with an inverse light microscope (Eclipse Ti-E, Nikon,
Japan).
Enzyme-linked immunosorbent assay (ELISA)
The concentrations of TNF-α and IL-1β in culture supernatants were measured by commercial
ELISA Kit (Boster Biological Technology, China) according to the manufacturer’s instructions.
The absorbance at 450 nm was determined using a microplate reader. The TNF-α and IL-1β
concentrations in culture supernatants calculated using TNF-α and IL-1β standards.
RT-PCR
Total RNA from cells were extracted by RNeasy Mini Kit (Qiagen, USA). Quality and quantity
of RNA were measured by NanoDrop 8000 spectrophotometer (Thermo Scientific). 1000 ng
RNA was used for each reaction to produce cDNA using high capacity cDNA reverse tran-
scription kit (Applied biosystems) following manufacturer's instructions. cDNA products were
diluted by adding RNase and DNase free water and frozen at -20°C before gene expression
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Data analysis was performed using the 2−ΔΔCt method.
Conditioned medium (CM)
BV2 cells were first cultured for 24 h in the BV2 culture medium, then the cell culture superna-
tants were replaced by DMEM-F12 FBS-free medium with or without LPS stimulation in the
absence or presence of cordycepin to culture another 24 h. CM were harvested, centrifuged for
5 min at 1000×g, filtered through 0.22-μm-pore-diameter Millipore filters, and then dialyzed
overnight using the Slide-A-Lyzer Dialysis Cassette (10K MWCO, Pierce Biotechnology Inc.,
USA) to exclude the possible influence of LPS. CMs were stored at -80°C until use.
Separation of Nuclei and Cytosol
Nuclei and cytosol were separated using a nuclear extract kit according to the manufacturer’s
instructions (Active Motif).
Immunostaining
The cells were treated following the protocols of the Fast ImmunoFluorescence Staining Kit
(BPIF30-1KT, Protein Biotechnologies, USA). The primary antibodies used were as follows:
anti-β-tubulin (Sigma), anti-actin (Sigma), MAP-2 (Sigma). For the measurement of the effect
of cordycepin on LPS-induced inflammatory responses, nuclei were stained with DAPI after
washing with phosphate-buffered saline, and fluorescence was visualized using a fluorescence
microscope (Carl Zeiss, Oberkochen, Germany).
Western blot
The expressions of p65, IкBα, p-IкBα and GAP43 were determined by western blotting and β-
actin was employed as control while HDAC1 was used as a control of p65 in nucleus. Cell ex-
tracts were lysed in RIPA buffer (Beyotime, China) containing Complete Protease Inhibitor
Cocktail and 2 mM PMSF. About 20 μg of total protein was separated by 10% SDS-PAGE and
transferred to 0.45 μmNitrocellulose Membrane (Millipore, USA). Protein concentrations
were determined by BCA Protein Assay Kit (Beyotime). The membranes were incubated with
primary antibodies at 4°C overnight and then hybridized with appropriate HRP-conjugated
secondary antibody (Amersham Pharmacia Biotech) at room temperature for 2 h. The results
were visualized using ECL kit (abcam) and observed by GeneGnome mechine (Syngene).
Transfection
The cultured hippocampal neurons were transfected with mCherry-actin at day 17 by the calci-
um phosphate method and the images were taken at day 21.
Effects of Cordycepin on Hippocampal Cultured Neurons
PLOS ONE | DOI:10.1371/journal.pone.0125902 May 1, 2015 4 / 18
Statistical analysis
All the experiments were performed in triplicate and data are shown as mean ± SEM based on
three separate experiments. Statistical analysis was performed using one-way ANOVA analysis
followed by Tukey’s tests and p< 0.05 was considered as statistical significant.
Results and Discussion
Effect of cordycepin on microglial cell viability
Prior to investigating the possible anti-inflammatory effects of cordycepin, we initially deter-
mined the effect of cordycepin on the cell viability of the microglial cells (BV2 cells in this
study). Four different concentrations of cordycepin (1, 10, 20 and 40 μg/ml) were employed,
according to our preliminary experiments and previous reports that investigated the effects of
different concentrations of cordycepin ranging from 5 to 40 μg/ml on cell viability [22, 23].
The cells under 1 and 10 μg/ml cordycepin treatment exhibited a similar cell density and mor-
phology as those without cordycepin treatment (control) (Fig 1A). Significantly reduced cells
were observed in the cultures with 20 or 40 μg/ml cordycepin treatments (Fig 1A). This was
further validated by MTT assay and LDH release assay. No differences of cell viability were
found between control, 1 and 10 μg/ml cordycepin treated groups, while cell viability were
Fig 1. Effects of different doses of cordycepin exposure on BV2microglia viability. (A) Representative photographs of microglia exposed to different
doses of cordycepin (0, 1, 10, 20, 40 μg/ml). Scale bar = 200 μm. (B) Relative cell viability of the microglia to the control following cordycepin treatment,
measured by MTT assay. (C) Relative LDH release to control in the experimental groups. The data were presented by the mean ± SEM. * p < 0.05.
doi:10.1371/journal.pone.0125902.g001
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significantly decreased when treated with 20 or 40 μg/ml of cordycepin (Fig 1B). Also, LDH
assays provided consistent result that cordycepin treatment with the concentrations less than
10 μg/ml had no obvious impairment on the integrality of the cell membrane (Fig 1C), as LDH
release indicates membrane damage and is a hallmark of necrosis. High concentrations of cor-
dycepin (20 or 40 μg/ml) could remarkably increase the LDH release compared to the control.
Therefore, the concentration of 10 μg/ml was decided to be used as an optimized concentration
for the following experiments.
Cordycepin attenuated the LPS-induced microglial over-activation
Microglia-mediated neurotoxicity has been most effectively demonstrated in models using LPS
[24], the polysaccharide component of the cell walls of gram-negative bacteria. LPS can induce
an obvious increase in the synthesis of inflammatory mediators, including various chemokines
and cytokines [25, 26], which has been reported to affect the neural cell behaviors and func-
tions [26, 27]. LPS was employed in our study based on two reasons. One is LPS-induced neu-
roinflammation could be a perfect positive control for us to evaluate the anti-inflammatory
effects of cordycepin. The other is we can investigate whether and how the cordycepin treat-
ment affects cell behaviors in the hippocampal neurons after microglia over-activation by LPS
insult. To study the anti-inflammatory effects of cordycepin on microglia, microglia cells were
cultured in the presence or absence of LPS (100 ng/ml, 24 h) with or without cordycepin treat-
ment (10 μg/ml). The microglial cells in these groups demonstrated a variety of morphological
characteristics, including amoeboid, spindle, ramified and spherical shapes, as shown in Fig
2A. We first examined the levels of two cytokines involved in the microglia induced inflamma-
tion in the experimental groups, tumor necrosis factor alpha (TNF-α) and interleukin-1 β (IL-
1β). TNF-α is a key mediator of inflammation involved in the initiation, regulation and perpet-
uation of the inflammatory response [28]. Anti-TNF-α strategies have been applied as a clinical
therapy for treating inflammatory diseases [29]. IL-1β is primarily a pro-inflammatory cyto-
kine that can be rapidly up-regulated to defend against infection and injury [30]. No significant
change was obtained in microglia without LPS stimulation. An increasing number of inflam-
matory diseases were found to be associated with the dysregulation of IL-1β activity [31, 32].
LPS significantly induced much higher levels of TNF-α and IL-1β release compared to control
(Fig 2B and 2C). The treatments of 10 μg/ml of cordycepin on LPS-stimulated microglia led to
significant decreases of TNF-α and IL-1β levels compared to the microglia with LPS stimula-
tion (Fig 2B and 2C), suggesting that cordycepin could attenuate the microglial over-activation
by LPS insult. Also, amyloid-beta (Aβ) was used to be another control to stimulate the micro-
glia. The results show that Aβ can also induce microglial activation and cordycepin successfully
reduced the Aβ-induced cytokine release (Fig. A in S1 File). Furthermore, we examined the ex-
pression of two important enzymes, inducible nitric oxide synthase (iNOS) and cyclooxygen-
ase-2 (COX-2), which are involved in the microglia mediated inflammation. Inducible nitric
oxide synthase (iNOS) plays a critical role in inflammation since it controls the production of
nitric oxide (NO) [33]. Cyclooxygenase-2 (COX-2) can be massively detected at the site of in-
flammation as a key enzyme involved in the release of prostaglandins regulating inflammation
[34, 35]. Given the improper elevation of iNOS and COX-2 occurring in several inflammatory
disorders and their contributions to mediate inflammatory processes [36], we evaluated the
mRNA expressions of iNOS and COX-2 in the cultures treated with cordycepin. No change
was observed when microglia was normally activated, whereas dramatically increased mRNA
expressions of iNOS and COX-2 were found in LPS-stimulated microglia. In the presence of
10 μg/ml of cordycepin, the mRNA levels of iNOS and COX-2 were both kept at control levels,
further indicating that cordycepin suppressed the LPS-induced inflammation. These results are
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Fig 2. Cordycepin attenuated the LPS-induced inflammatory responses. (A) Representative images of microglia following 10 μM cordycepin treatment
for 1 day with or without LPS treatment. Cells were stained green for tubulin, blue for nucleus. Scale bar = 100μm. The contents of cytokines, including TNF-α
(B) and IL-1β (C) in the experimental groups were measured by the ELISA assay. Note the obviously lower concentrations of TNF-α and IL-1β in cordycepin
treatment group compared to untreated group after LPS stimulation. (D-E) Relative mRNA levels of iNOS and COX-2 in the experimental groups assessed
by real time PCR using the 2-ΔΔCT method. Data are expressed as the fold change in gene expression normalized to an endogenous gene (β-actin) and
relative to the cells in control group without LPS stimulation. Data are presented as mean ± SEM (n = 6 in triplicate). # p < 0. 01.
doi:10.1371/journal.pone.0125902.g002
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consistent with a previous study that showed 1h pre-treatment of cordycepin (1~7.5 μg/ml)
was able to inhibit both pretranslational and translational levels of iNOS and COX-2 and
mRNA expressions of TNF-α and IL-1β in LPS-stimulated BV2 microglia [7]. The transcrip-
tion of iNOS and COX-2 can be activated by NF-κB, while TNF-α and IL-1β are involved in
the activation of NF-κB pathway [36–39], implying a possible connection between the anti-in-
flammatory role of cordycepin and NF-κB signaling pathway.
Cordycepin inhibited NF-κB signaling pathway
To further investigate the mechanism of anti-inflammatory effect of cordycepin, we examined
the NF-κB signaling pathway during the cordycepin treatment. The expressions of p65, IκBα,
and phosphorylated IκBα (p-IκBα) were measured. Fig 3A shows the representative images of
protein bands measured by western blotting analysis, including p65, IκBα and p-IκBα in the
cytoplasm, in the different experimental groups. Fig 3B, 3C and 3D illustrate the relative ex-
pression of p65, IκBα and p-IκBα in the cytoplasm normalized by β-actin. P65 expression was
dramatically decreased in LPS-stimulated microglia, while it was significantly increased nearly
to the level in control (without LPS and cordycepin treatment) by cordycepin treatment in
LPS-stimulated group (Fig 3B). Similar results could be observed in the IκBα expression in the
cytoplasm. It was significantly decreased by LPS stimulation compared to control. Cordycepin
treatment strikingly elevated IκBα expression in the cytoplasm to a comparable level to control
in the LPS-stimulated culture (Fig 3C). In contrast, the p-IκBα expression was significantly
higher in the cultures after LPS stimulation compare to control group, while it was dropped to
the level of control by cordycepin treatment in LPS-stimulated cultures (Fig 3D). Furthermore,
the expression of p65 in the nucleus was also examined (Fig 3E and 3F). Higher level of p65 in
the nucleus was found in LPS-stimulated microglia, accounting for the decrease of p65 in the
cytoplasm. These results revealed the occurrence of the translocation of p65 from cytoplasm to
nucleus and the activation of NF-κB in LPS-stimulated microglia. However, p65 level in the
nucleus was decreased in LPS-stimulated microglia after cordycepin treatment.
NF-κB is well-known to play ubiquitous roles in inflammation and immunological process-
es and also control cell division and apoptosis. It is employed by several distinctive biological
cellular activities including inhibiting bone formation and cellular responses to injury of the
nervous system [40, 41]. The TNF pathway involved in inflammatory response is one of the
most widely-known characterized NF-κB-dependent pathways. In the nervous system, TNF
can be activated by NF-κB and binds to TNF receptors expressed on neurons and microglia.
P50, RelA/p65 and IκBα are the three most important proteins to activate NF-κB. In fact, the
unphosphorylated IκBα protein mainly maintains the inactivated states of NF-κB proteins, in-
cluding p50, p52, RelA/p65, and RelB [41]. Phosphorylation of IκBα by IκB kinase (IKK) is
thought to be the central part of NF-κB signaling pathway, which leads to the ubiquitination
and degradation of IκBα and in turn releases NF-κB proteins [42]. The released NF-κB pro-
teins then translocate from cytoplasm to the nucleus to regulate cellular activities [42]. It was
documented that LPS-stimulated rats contained increased transcriptional activation of IκB in
microglia throughout the brain [43]. In addition, multiple studies have proposed the involve-
ment of NF-κB in the activation of microglia [44, 45], and provided the evidence of the role of
NF-κB in LPS-stimulated inflammation and the relation between NF-κB and microglia. Our
results clearly demonstrated the ability of cordycepin to inhibit NF-κB signaling pathway in
the induction of LPS-stimulated inflammation. This is in agreement with a previous study
which revealed that pre-treatment of cordycepin suppressed the LPS-induced translocations of
p65 to nucleus and blocked the LPS-stimulated degradation of IκB-α in BV2 cells [7]. Taken
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Fig 3. Cordycepin (10 μg/ml) inhibited NF-кB signaling pathway activated by LPS treatment. (A) The p65, IкBα and p-IкBα protein expression in the
cytoplasm in the cultures under cordycepin treatment with or without LPS stimulation. (B-D) The relative optical densities of p65, IкBα and p-IкBα protein
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together, cordycepin has a potent clinical application value for not only preventing but also
treating neuro-inflammation.
Cordycepin treatment rescued the LPS-CM-induced neuronal death
To investigate the beneficial effects of cordycepin on neural growth and development, we next ex-
amined the role of cordycepin in protecting neural death by LPS-induced microglial over-activa-
tion in the cultured hippocampal neurons. Firstly, we collected conditioned medium (CM)
before performing turning experiments (see Methods and Materials section). CMs frommicro-
glia enriched cultures in the absence (control-CM) or presence of 10 μg/ml cordycepin (Cordyce-
pin-CM) were prepared with (LPS-CM) or without LPS stimulation. Cell viability of the
hippocampal neurons cultured in different CMs for 7 days was examined by MTT and LDH
assay. The cell viability in the LPS-CM group was significantly declined compared to the control
group (Fig 4A), indicating LPS-induced microglial over-activation may be harmful to the neu-
rons. In contrast, 10 μg/ml cordycepin treatment greatly improved cell viability in the LPS-CM.
LDH release results were also consistent with the above results (Fig 4B). Significantly higher level
of LDH was released in LPS-CM cultured neurons in comparison with control group, whereas
cordycepin treatment reversed this elevated LDH release, suggesting that the viability of neurons
were improved. This was also verified in Aβ-stimulated situation (Fig. B in S1 File).
Cordycepin protected the impairment of growth cone (GC) by microglial
overactivation
Activated microglia increases the production of a variety of cytokines that have been shown to
inhibit axonal growth [46–48]. Neurite exploration is guided by GCs located at their tip [49–
bands to control, normalized to β-actin. (E) The p65 expression in the nucleus in the experimental groups. (F) The relative optical densities of p65 protein
bands to control, normalized to HDAC1. Data were presented by mean ± SEM. *p < 0.05, #p < 0.01.
doi:10.1371/journal.pone.0125902.g003
Fig 4. Cordycepin (10 μg/ml) rescued LPS-induced cell death in the hippocampal neurons. The cells were cultured for 7 days in the different
conditioned mediums of the experimental groups. (A) Relative cell viabilities to control in the experimental groups, examined by MTT assay. (C) Relative LDH
release to control in the experimental groups. Data were presented by mean ± SEM. *p < 0.05.
doi:10.1371/journal.pone.0125902.g004
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51], formed by an extended lamellipodium from which thin filopodia emerge [52]. Firstly, we
tried to determine the influence of cordycepin treatment on GCs extension and formation. The
morphology of GCs was observed under fluorescence microscope by actin and β-tubulin label-
ing. Fig 5A shows representative images of GC with actin rich peripheral zone (green) and mi-
crotubule-rich central core (red). The normalized area of GC to control in the hippocampal
cultures was significantly reduced by LPS-CM culturing, while the cordycepin treatment prom-
isingly reversed this reduction (Fig 5B). Filopodia, which radiates out from the central core of
GC, functions as the probe to detect the surrounding environment [53, 54]. The number of
filopodia of each GC was significantly decreased in LPS-CM cultured neurons, and it can be
rescued by cordycepin treatment as indicated by a significant increase in the number of filopo-
dia, suggesting the impairments of inflammation on the development of neurons. However,
cordycepin may repair this effect by promoting the formation of filopodia, accounting for the
increase of the number of filopodia in each GC by cordycepin treatment. Although no change
of filopodium length was observed between different CMs treatments groups, the density of
filopodia (number of filopodia/GC area) was reduced in LPS-CM cultured neurons compared
to control group. GC density was significantly improved by cordycepin treatment in LPS-CM
cultured neurons. Since the primary function of filopodia is to sense the factors released by
other cells in the surrounding environment and transduce the signals to their parent growth
cone, the disruption of the growth of filopodia can be related to the deficits of axonal transport,
resulting in various brain disorders such as chronic neurodegenerative disease [55]. These re-
sults verified the impairments of GC extension and filopodia density by microglial over-activa-
tion and the capability of cordycepin in protecting neural impairments by inflammation.
Cordycepin promoted neurite sprouting and outgrowth impaired by the
LPS-CM
The neurons begun to extend neurites into the periphery after the neurons were seeded to the
plates until they were mature. At day 7 after neurons were seeded, we studied the effects of cor-
dycepin on the neurite sprouting and outgrowth by characterizing neurite density, length and
complexity in the hippocampal neurons cultured in different CMs. Fig 6A shows typical hippo-
campal neurons with extending neurites stained by MAP-2, a maker for mature neurons, in
different experimental groups. Significant decrease in the primary dendrites per neuron was
observed in the LPS-CM cultured cells compared to control, while cordycepin significantly re-
covered the loss of neurites (Fig 6B). Similarly, LPS-CM could clearly reduce the numbers of
dendritic end tips and the average length of neurites compared to control, indicating an inhibi-
tory effects on neurite outgrowth (Fig 6C and 6D). As expected, cordycepin treatment exerted
a protective role against the LPS-CM-induced impairments by promoting the number of den-
dritic tips as well as the averaged neurite length to a normal level of control (Fig 6C and 6D).
These results provide strong evidences that cordycepin protects neurite sprouting and out-
growth in the event of microglial over-activation. We also measured the expression of growth
associated protein 43 (GAP43), a protein considered to be a crucial factor involved in the
neuronal development and plasticity [56, 57]. The expression of GAP43 in the cultures was sig-
nificantly reduced in LPS-CM group compared to control (Fig 7E and 7F). As expected, cordy-
cepin treatment led to a significant increase of GAP43 expression compared to LPS-CM group.
This result further suggested that cordycepin is able to recover the impairments of neural
growth and development after microglial over-activation.
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Fig 5. Cordycepin (10 μg/ml) rescued the LPS-induced impairments of GCs. The hippocampal neurons were cultured for 1 day in the different conditioned
mediums of the experimental groups. (A) Representative fluorescence images of the hippocampal GC stained for actin, tubulin and merge of the two staining.
Scale bar = 20 μm. (B) Relative area of GCs to control. (C) Average number of filopodia emerging fromGCs. (D) Average filopodium lengths from the tip of each
filopodia to the edge of the GCs. (E) Ratio of number of filopodia and area of GC in GCs. Data were presented bymean ± SEM. * p < 0.05.
doi:10.1371/journal.pone.0125902.g005
Fig 6. Cordycepin treatment (10 μg/ml) could repair the LPS-induced injuries of neurite sprouting and outgrowth. The hippocampal neurons were
cultured for 7 day in the different conditioned mediums of the experimental groups. (A) Typical hippocampal neurons with extending neurites in the culture in
different experimental groups, stained for MAP-2. The neurite sprouting and outgrowth were characterized by the number of primary dendrites per cell (B),
number of dendritic end tips (C) and the average neurite length (D) in the experimental groups. (E) Western blot analysis of GAP-43 expression in the
cultures of different groups. (F) Relative optical densities of GAP-43 show in (E) (n = 3/group). Data were presented by mean ± SEM. * p < 0.05, #p < 0.01.
doi:10.1371/journal.pone.0125902.g006
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Effect of cordycepin on the spinogenesis
Finally, we examined the effect of cordycepin on spinogenesis by observing the changes of
spine morphology and density in different cultures of CMs. The neurons were cultured for 17
days and were transfected with mCherry-actin. At day 21, the neurons with spines can be clear-
ly visualized by confocal microscopy. Fig 7A shows the images of the neurite with spine in a
Fig 7. Effects of cordycepin treatment on spine morphology and density in the hippocampal neurons. (A) The cultured hippocampal neurons were
transfected with mCherry-actin and imaged. The spine in the experimental groups could be clearly observed at high magnification. Scale bar = 2 μm. (B)
Proportion of different spine types expressed as percentage of total spines in the neurons in the experimental groups. (C) Spine density expressed as
number of spines per 10 μm of dendrites of the neurons in the experimental groups. Data were presented by mean ± SEM. * p < 0.05.
doi:10.1371/journal.pone.0125902.g007
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higher magnification. The proportions of different spine types (stubby, mushroom, thin) were
compared among the four experimental groups. No significant difference was observed among
these groups (Fig 7B), indicating that neither LPS-CM nor cordycepin treatment can influence
the spine morphology after the neurons matured. However, the spine density in the neurons
cultured in LPS-CM was significantly lower compared to that of control (Fig 7C). Remarkably,
increased spine density was also observed in the hippocampal neurons after cordycepin
treatment.
Taken all together, these results provided supportive evidence of the protective role of cor-
dycepin against the impairments of brain caused by neuroinflammation by inhibiting TNF-α,
IL-1β, iNOS and COX-2. It was also indicated that neural development were facilitated by cor-
dycepin treatment. Previous study demonstrated that 20 mg/kg cordycepin taken orally had
the capacity to decrease plasma IL-1β and TNF-α in mice [58]. Moreover, a study on the role
of cordycepin in cerebral ischema/reperfusion validated the potent neuroprotective function of
cordycepin in vivo [6]. These studies suggest that cordycepin may penetrate brain and act as an
anti-inflammatory agent in treating brain injury. However, if cordycepin is effective to be used
in treating microglia-overactivation-induced inflammatory damage of brain still needs in vivo
experiments in further study.
In conclusion, we report here that cordycepin possess anti-inflammatory effects in LPS-in-
duced microglial activation via inhibiting NF-κB signaling pathway. Cordycepin treatment is
able to recover the neuronal death caused by microglial over-activation and successfully rescue
the inflammation-induced impairments of neural growth and development in the hippocampal
cultured neurons, as indicated by improved growth cone extension, neurite sprouting and out-
growth and spinogenesis. Our study demonstrates the neuroprotective role of cordycepin
against neuroinflammation-induced impairments and suggests the potential of cordycepin as
an alternative therapeutic approach to treat brain injuries.
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